Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bastide Le Confort MedicalLTS:0IP1 71 EV-to-EBIT is 11.19 as of Jul. 30, 2026, which is 47% below its 10-year median of 21.17. GuruFocus rates LTS:0IP1 with a GF Score™ of 71/100 and a GF Value™ of €25.99 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 94 Medical Distribution companies, Bastide Le Confort Medical ranks better than 50% on this metric.
Bastide Le Confort Medical (LTS:0IP1) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Bastide Le Confort Medical's Enterprise Value for the quarter that ended in Dec. 2025 was €476.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bastide Le Confort Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €41.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bastide Le Confort Medical EV-to-EBIT Related Terms
Bastide Le Confort Medical EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Bastide Le Confort Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bastide Le Confort Medical EV-to-EBIT vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Bastide Le Confort Medical's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Bastide Le Confort Medical's EV-to-EBIT falls into.
Bastide Le Confort Medical's current Enterprise Value is €466.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bastide Le Confort Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €41.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bastide Le Confort Medical (LTS:0IP1) has a EV-to-EBIT of 11.19 as of Jul. 30, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Bastide Le Confort Medical and its competitors. This is 47% below median its historical median of 21.17. Over the past decade, Bastide Le Confort Medical's EV-to-EBIT has ranged from 11.19 to 50.55. According to the industry distribution chart, Bastide Le Confort Medical ranks #47 out of 94 companies in the Medical Distribution industry, placing it in the top 50%.
Is Bastide Le Confort Medical's EV-to-EBIT too high?
Bastide Le Confort Medical's current EV-to-EBIT of 11.19 is 47% below median its 10-year median of 21.17. Over the past 10 years, this metric has ranged from a low of 11.19 to a high of 50.55. The Medical Distribution industry median EV-to-EBIT is 11.78. Bastide Le Confort Medical's value of 11.19 is 5% below this industry median. Based on the distribution chart, Bastide Le Confort Medical ranks #47 out of 94 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Bastide Le Confort Medical has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bastide Le Confort Medical's EV-to-EBIT compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Bastide Le Confort Medical ranks #47 out of 94 companies for EV-to-EBIT. This puts Bastide Le Confort Medical in the upper half of its industry. The industry median EV-to-EBIT is 11.78. Bastide Le Confort Medical's value of 11.19 is 5% below this benchmark. Historically, Bastide Le Confort Medical's own EV-to-EBIT has ranged from 11.19 to 50.55 over the past decade. While the company's 10-year median is 21.17 vs. the industry median of 11.78, Bastide Le Confort Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 11.78, based on 94 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bastide Le Confort Medical's current EV-to-EBIT of 11.19 is 5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Bastide Le Confort Medical and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 11.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bastide Le Confort Medical's current EV-to-EBIT is 11.19, which is 47% below median its own 10-year median of 21.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bastide Le Confort Medical stock overvalued right now?
Based on GuruFocus' analysis, Bastide Le Confort Medical (LTS:0IP1) is currently considered Modestly Undervalued. The stock's GF Value™ is €25.99, compared to a current price of €23.05 — trading 11.3% below its estimated fair value. The current EV-to-EBIT is 11.19, which is 47% below median its 10-year median of 21.17 and 5% below the Medical Distribution industry median of 11.78. Bastide Le Confort Medical's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Bastide Le Confort Medical (LTS:0IP1), the current EV-to-EBIT is 11.19 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bastide Le Confort Medical (LTS:0IP1) Overvalued in 2026?
Based on GuruFocus' analysis, Bastide Le Confort Medical stock appears to be undervalued.
The current stock price of €23.05 is trading 11.3% below its estimated GF Value™ of €25.99.
GuruFocus considers Bastide Le Confort Medical to be Modestly Undervalued.
Key valuation signals for LTS:0IP1:
EV-to-EBIT: 11.19 (47% below median its 10-year median of 21.17)
GF Value™: €25.99 vs. price of €23.05 (11.3% below fair value)
Industry Position: 5% below the Medical Distribution median (#47 of 94)
No single metric tells the full story. See the LTS:0IP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bastide Le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for the home care of the elderly, sick and disabled. The company provides care equipment, such as hospital beds, personal assistance products, nutrition, insulin pumps, and syringe-drivers.
71GF Score
Get the complete analysis for LTS:0IP1
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0IP1 has been successfully added to your 
